Abstract
The pancreas houses insulin, the most powerful known metabolic regulator. In addition to the β cell, Langerhan’s pancreatic islets also contain D cells producing somatostatin, a cells producing glucagon and PP cells producing pancreatic polypeptide (Fig. 1). Between them these cells have the power to stimulate or suppress numerous physiological functions. A major and frequent challenge to the constancy of the “milieu intérieur” is the daily ingestion of food. The smooth assimilation of oral nutriments requires an efficiently controlled digestive process and a precise adjustment of metabolic regulators. To this end a complicated control system exists. This is partly neural, thus allowing an early flow of information from the anticipation, smell and taste of food, and partly hormonal, utilising the diffuse endocrine system of the gut to produce an integrated signal proportional to the amount and type of food ingested. Only if the first two mechanisms fail to fully adjust metabolic regulators, such as pancreatic insulin, would a significant disturbance of circulating nutriments occur and stimulate the pancreatic islets directly.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adrian TE, Bloom SR, Bryant MG, Polak JM, Heitz Ph, Barnes AJ: Distribution and release of human pancreatic polypeptide, Gut 17: 940–944, 1976
Solcia E, Polak JM, Pearse AGE, Forssman WG, Larsson L-I, Sundler F, Lechago J, Grimelius L, Fujita T, Creutzfeldt W, Gepts W, Falkmer S, Lefranc G, Heitz Ph, Hage E, Buchan AMJ, Bloom SR, Grossman MI: Lausanne 1977 classification of gastroenteropancreatic endocrine cells. In: Gut Hormones, edited by SR Bloom, Churchill Livingstone, Edinburgh, 1978, p. 40–48
Kimmel JR, Hayden LJ, Pollock HG: Isolation and characterization of a new pancreatic polypeptide hormone. J. Biol. Chem. 250: 9369–9376, 1975
Adrian TE, Greenberg GR, Besterman HS, McCloy RF, Chadwick VS, Barnes AJ, Mallinson CN, Baron JH, Alberti KGMM, Bloom SR: PP infusion in man — summary of initial investigation. In: Gut Hormones, edited by SR Bloom, Churchill Livingstone, Edinburgh, 1978, p. 265–267
Adrian TE, Bloom SR, Besterman HS, Barnes AJ, Cooke TJC, Russell RCG, Faber RG: Mechanism of pancreatic polypeptide release in man. Lancet I: 161–163, 1977
Adrian TE, Bloom SR, Hermansen K, Iversen J: Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas. Diabetologia, in press
Mortimer CH, Carr D, Lind T, Bloom SR, Mallinson CS, Schally AV, Tunbridge WMG, Yeomans L, Coy DH, Kastin A, Besser GM: Growth hormone release inhibiting hormone: effects on circulating glucagon, insulin and growth hormone in normal, diabetic, acromegalic and hypopituitary patients. Lancet I: 697–701, 1974
Nabarro JDN, Hall R, Besser GM, Coy DH, Kastin AJ, Schally AV: Glucagon control of fasting glucose in man. Lancet II: 974, 1974
Bloom SR: Glucagon: a stress hormone. Postgraduate Medical Journal 49: 607–612, 1973
Bloom SR, Edwards AV, Vaughan NJA: The role of the sympathetic innervation in the control of plasma glucagon concentration in the calf. J. Physiol. 233: 457–466, 1973
Bloom SR, Edwards AV, Vaughan NJA: The role of the autonomic innervation in the control of glucagon release, J. Physiol, 236: 611–624, 1974
Bloom SR, Edwards AV, Hardy RN, Malinowska K, Silver M: Cardiovascular and endocrine responses to feeding in the young calf. J. Physiol. 253: 135–155, 1975
Brown JC, Mutt V, Pederson RA: Further purification of a polypeptide demonstrating enterogastrone activity, J. Physiol. 209: 56–64, 1970
Pederson RA, Schubert HE, Brown JC: Gastric inhibitory polypeptide. Diabetes 24: 1050–1056, 1975
Dupre J, Ross SA, Watson D, Brown JC: Stimulation of insulin secretion by gastric inhibitory peptide in man. J. Clin. Endocrinol. Metab. 37: 826–828, 1973
Besterman HS, Bloom SR, Sarson DL, Blackburn AM, Johnston DI, Patel HR, Stewart JS, Modigliani R, Guerin S, Mallinson CN: Characteristic gut hormone profile in coeliac disease. Lancet, in press
Brown M, Vale W: Effects of neurotensin and substance P on plasma insulin, glucagon and glucose levels. Endocrinology 98: 819–825, 1976
Woods SC, Porte D: Neural control of the endocrine pancreas. Physiol. Rev. 54: 596–619, 1974
Bloom SR, Edwards AV: The release of pancreatic glucagon and inhibition of insulin in response to stimulation of the sympathetic innervation. J. Physiol. 253: 157–173, 1975
Bloom SR, Edwards AV, Hardy RN: The role of the autonomic nervous system in the control of pancreatic endocrine responses to the ingestion of milk in the conscious calf, J. Physiol., in press
Polak JM, Pearse AGE, Grimelius L, Bloom SR, Arimura A: Growth hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet I: 1220–1225, 1975
Bloom SR, Edwards AV: Effects of certain inhibitory or blocking agents on the release of pancreatic glucagon in response to stimulation of the splanchnic nerves. J, Physiol., in press
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Bloom, S.R., Polak, J.M. (1978). Enteropancreatic Axis. In: Grossman, M., Speranza, V., Basso, N., Lezoche, E. (eds) Gastrointestinal Hormones and Pathology of the Digestive System. Advances in Experimental Medicine and Biology, vol 106. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7248-6_19
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7248-6_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7250-9
Online ISBN: 978-1-4684-7248-6
eBook Packages: Springer Book Archive